These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4631868)

  • 1. Anti-C3a, anti-C3B (anti-B) and their reaction with the anaphylatoxic fragment C3a.
    Molenaar JL; ten Velde A; Pondman KW
    J Immunol; 1973 Mar; 110(3):702-8. PubMed ID: 4631868
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in antigenic properties of human C3 upon activation and conversion by trypsin.
    Molenaar JL; Müller MA; Engelfriet CP; Pondman KW
    J Immunol; 1974 Apr; 112(4):1444-51. PubMed ID: 4205530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of specific binding activity of guinea pig complement C3 by dithiothreitol].
    Takahashi S; Tanaka K; Kono H; Takahashi M
    Arerugi; 1972 Jan; 21(1):40-9. PubMed ID: 4623566
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
    Goldlust MB; Shin HS; Hammer CH; Mayer MM
    J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
    [No Abstract]   [Full Text] [Related]  

  • 5. Passive immune lysis with chromic chloride-treated erythrocytes.
    Perucca PJ; Faulk WP; Fudenberg HH
    J Immunol; 1969 Apr; 102(4):812-20. PubMed ID: 5768191
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement receptors on cell membranes. I. Evidence for two complement receptors.
    Okada H; Nishioka K
    J Immunol; 1973 Nov; 111(5):1444-9. PubMed ID: 4795622
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Isolation of C3b receptors from human erythrocytes.
    Okuda T; Tachibana T
    Jpn J Exp Med; 1976 Jun; 46(3):201-3. PubMed ID: 957525
    [No Abstract]   [Full Text] [Related]  

  • 10. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
    Winkelstein JA; Shin HS; Wood WB
    J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
    [No Abstract]   [Full Text] [Related]  

  • 11. The demonstration of the sensitizing effect of the residual animal serum content of vaccines.
    Erdös L; Láng CS; Jaszovszky I; Nyerges G
    Ann Immunol Hung; 1973; 17():79-83. PubMed ID: 4218939
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD
    J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
    Drake WP; Pokorney DR; Mardiney MR
    J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
    [No Abstract]   [Full Text] [Related]  

  • 14. Rat 7S immunoglobulins: characterization of gamma-2- and gamma-1-anti-haptens antibodies.
    Jones VE
    Immunology; 1969 May; 16(5):589-99. PubMed ID: 4977835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of rabbit anti-rat epidermal cell sera. Demonstration of tissue-specific differentiation antigens.
    Lloyd KO; Darnule TV
    J Immunol; 1974 Jan; 112(1):311-9. PubMed ID: 4130150
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin reactions induced by sera of patients with monoclonal IgG gammapathy.
    Yoshida H; Kasukawa R; Yoshida T; Kano K
    Int Arch Allergy Appl Immunol; 1973; 45(4):620-30. PubMed ID: 4200919
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction.
    May JE; Frank MM
    J Immunol; 1972 Jun; 108(6):1517-25. PubMed ID: 4537434
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune adherence reactions of human erythrocytes sensitized with complement in vitro and in vivo.
    Petz L; Fudenberg HH; Fink D
    J Immunol; 1971 Dec; 107(6):1714-22. PubMed ID: 5120402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.